On further time-based analysis, we demonstrated a modest reduction in weight with GLP-1 RA use within the first 3 years (2.7% of baseline body weight) before rebounding to above baseline at 5 years
Notably, the observed variability in efficacy between agents, particularly in the early phases of treatment, emphasizes the importance of individualized therapeutic strategies, tailored to specific clinical goals, baseline metabolic profiles, and patient preferences
We explore the anxiety surrounding muscle loss and Ozempic face, and the massive white-space opportunity for Companion Brands and Transformation Kits to formulate for tolerance and symptom-management, rather than just taste
Its essential to inform both your prescribing physician and mental health provider about all medications youre taking, including GLP-1 inhibitors, to ensure comprehensive care and monitoring
Acta Anaesthesiol Scand